Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Dexcom (DXCM)

Dexcom promotes CFO Jereme Sylvain to chief operating officer, effective September 14, 2026

Neutral Impact 4 of 5 leadership Written later

DexCom named Jereme Sylvain, its executive vice president and chief financial officer, to also serve as chief operating officer, effective September 14, 2026, with oversight of global operations and quality teams. His new offer letter sets a base salary of $767,000 and a target bonus of 75% of base salary.

Key points

  • Sylvain keeps his CFO role and adds the COO title, effective September 14, 2026
  • Base salary of $767,000; annual target bonus equal to 75% of base salary
  • Offer letter dated September 11, 2026; a copy will be filed with the 10-Q for the quarter ended September 30, 2026
  • CEO Jake Leach said Sylvain will help the company scale more effectively

The filing

CompanyDexcom (DXCM)
Form8-K, current report
Filed with the SECSep 14, 2026, 4:33 PM ET
Accession number0001093557-26-000175

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 14, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.